Invasion as limitation to anti-angiogenic glioma therapy

Acta Neurochirurgica, Supplementum

Volumn , Issue 88, 2003, Pages 169-177

  Lamszus, K ^a   Kunkel, P ^a   Westphal, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Angiogenesis; Glioma invasion; Vessel cooption

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ANIMAL; BRAIN; BRAIN TUMOR; CANCER INVASION; CANCER TRANSPLANTATION; DRUG ANTAGONISM; DRUG EFFECT; GLIOMA; HUMAN; MICROCIRCULATION; MOUSE; PATHOLOGY; RAT; REVIEW; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; BRAIN NEOPLASMS; GLIOMA; HUMANS; MICE; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 0347378566     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6090-9_23     Document Type: Review

References (36)

1. Brem S, Cotran R, Folkman J (1972) Tumor angiogenesis: a quantitative method for histologie grading. J Natl Cancer Inst 48:347-356
2. Kleihues P, Cavenee WKe (2000) World health organization classification of tumours. I ARC Press, Lyon
3. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186
4. Folkman J (1995) Tumor angiogenesis. WB Saunders, Philadelphia, pp 206-232
5. Scherer H J (1940) The forms of growth in gliomas and their practical significance. Brain 63: 1-35
6. Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207-218
7. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC (1994) Quantitative immunohistological analysis of the mi-crovasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 81: 902-909
8. Schiffer D, Chio A, Giordana MT, Mauro A, Migheli A, Vig-liani MC (1989) The vascular response to tumor infiltration in malignant gliomas. Morphometry and reconstruction study. Acta Neuropathol (Berl) 77: 369-378
9. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter KC, Harris AL, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151:1417-1423
10. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Vancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angio-poietins and VEGF. Science 284: 1994-1998
11. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, Zabski S, Yancopoulos GD, Grumet M (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80: 837-849
12. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Filibrandt R, Stavrou D, Westphal M, Lamszus K (2001) Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61: 6624-6628
13. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G (2002) Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 109: 777-785
14. Nagano N, Sasaki H, Aoyagi M, Hirakawa K (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol (Berl) 86: 117-125
15. Bernstein JJ, Woodard CA (1995) Glioblastoma cells do not intravasale into blood vessels. Neurosurgery 36: 124-132; discussion 132
16. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59: 5209-5218
17. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844
18. Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29: 10-14
19. Shibuya M (2001) Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 33:409-420
20. Lamszus K, Ulbricht U, Matschke J, Brockmann MA, Fill-brandt R, Westphal M (2003) Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A. Clin Cancer Res 9 (in press)
21. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Pérsico MG (2001) Synergism between vascular endothelial growth factor and placental growth factorcontributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583
22. Schmidt NO, Westphal M, Hagel C, Ergun S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84: 10-18
23. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189-1193
24. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2: 306-314
25. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579
26. Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401
27. Vajkoczy P, Menger MD, Vollmar B, Schilling L, Schmiedek P, Hirth KP, Ullrich A, Fong TA (1999) Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1: 31-41
28. Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS, Soffer SZ, Ring L, New T, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ (2002) Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proc Natl Acad Sci USA 99: 11399-11404
29. Skobe M, Rockwell P, Goldstein N, Vosseier S, Fusenig NE (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3: 1222-1227
30. Thompson WD, Shiach KJ, Fräser RA, Mcintosh LC, Simpson JG (1987) Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 151: 323-332
31. Piasswilm L, Tannapfel A, Cordes N, Demir R, Hoper K, Bauer J, Hoper J (2000) Hypoxia-induced tumour cell migration in an in vivo chicken model. Pathobiology 68:99-105
32. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL (2001) Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 158: 1325-1334
33. Tamaki M, McDonald W, Amberger VR, Moore E, Del Maestro RF (1997) Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations. J Neurosurg 87: 602-609
34. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80: 617-623
35. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143
36. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7: 987-989